or Try an Advanced Search...

    Technical Analysis for TSBX - Turnstone Biologics Corp.

    Grade Last Price % Change Price Change
    F 0.49 -7.12% -0.04
    TSBX closed down 7.12 percent on Friday, November 15, 2024, on 44 percent of normal volume.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical TSBX trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 0.00%
    1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
    Down 3 Days in a Row Weakness 0.00%
    50 DMA Resistance Bearish -7.12%
    20 DMA Support Bullish -7.12%
    Calm After Storm Range Contraction -7.12%
    Gapped Down Weakness -7.12%
    Fell Below 50 DMA Bearish -8.20%
    Calm After Storm Range Contraction -8.20%
    Inside Day Range Contraction -8.20%
    Older End-of-Day Signals for TSBX ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Lower Bollinger Band 1 day ago
    1.5x Volume Pace 1 day ago
    Down 10% 1 day ago
    Down 1 ATR 1 day ago
    Down 5% 1 day ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    TSBX Chart by TradingView
    Basic chart:

    Profile

    Turnstone Biologics Corp. Description

    Turnstone Biologics is a clinical-stage biotechnology company developing new medicines to treat and cure solid tumors by pioneering a differentiated approach to TIL therapy. Turnstone’s innovative TIL therapy is based upon the identification, selection, and expansion of the most potent tumor-reactive T cells, known as Selected TILs, and is designed to overcome the limitations of first-generation bulk TILs that have demonstrated objective responses only in limited tumor types. Turnstone’s most advanced program, TIDAL-01, is currently being evaluated in two Phase 1 studies in patients with melanoma, breast cancer, and colorectal cancer, and the Company is also actively advancing its preclinical pipeline programs including TIDAL-02, its next Selected TIL program, and its TIDAL-01 and viral immunotherapy combination program.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Solid Tumors Immunotherapy Breast Cancer Melanoma Colorectal Cancer Tumor Infiltrating Lymphocytes

    Is TSBX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 12 Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
    Nov 5 Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
    Oct 12 Turnstone Biologics Streamlines Operations and Leadership
    Oct 11 FDA clears Roche breast cancer drug; Turnstone lays off 60% of staff
    Oct 11 Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway
    Aug 15 Turnstone Biologics Shifts Focus To 'High Unmet Medical Need' Cancers, Shares Initial Data From Colorectal Cancer Cell Therapy Study
    Aug 15 Dow Surges Over 500 Points; US Retail Sales Rise In July
    Aug 14 Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights
    Aug 14 Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer
    Aug 12 Turnstone Biologics Corp. (TSBX): This Penny Stock is a ‘Strong Buy’ According to Analysts
    See more TSBX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.75
    52 Week Low 0.4393
    Average Volume 320,800
    200-Day Moving Average 2.08
    50-Day Moving Average 0.54
    20-Day Moving Average 0.52
    10-Day Moving Average 0.52
    Average True Range 0.06
    RSI (14) 44.44
    ADX 33.79
    +DI 23.53
    -DI 19.00
    Chandelier Exit (Long, 3 ATRs) 0.52
    Chandelier Exit (Short, 3 ATRs) 0.61
    Upper Bollinger Bands 0.57
    Lower Bollinger Band 0.46
    Percent B (%b) 0.29
    BandWidth 22.93
    MACD Line -0.01
    MACD Signal Line -0.02
    MACD Histogram 0.0089
    Fundamentals Value
    Market Cap 11.32 Million
    Num Shares 23.1 Million
    EPS -2.27
    Price-to-Earnings (P/E) Ratio -0.22
    Price-to-Sales 2.13
    Price-to-Book 0.56
    Dividend 0.00
    Dividend Yield 0.00%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.59
    Resistance 3 (R3) 0.59 0.56 0.57
    Resistance 2 (R2) 0.56 0.53 0.56 0.57
    Resistance 1 (R1) 0.52 0.52 0.51 0.52 0.56
    Pivot Point 0.49 0.49 0.49 0.49 0.49
    Support 1 (S1) 0.46 0.47 0.44 0.46 0.42
    Support 2 (S2) 0.43 0.45 0.43 0.41
    Support 3 (S3) 0.39 0.43 0.41
    Support 4 (S4) 0.39